Form 144(Amend) | GeneDx Holdings(WGS.US) 10% Stockholder Proposes to Sell 36.49 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Jun 28, $GeneDx Holdings(WGS.US)$、$GENEDX HOLDINGS CORP C/WTS 22/07/2026 (TO PUR COM)(WGSWW.US)$ 10% Stockholder OPKO HEALTH, INC. intends to sell 1.37 million shares of its co

Moomoo NewsJun 28 10:22 ET

Form 144 | GeneDx Holdings(WGS.US) 10% Stockholder Proposes to Sell 6.96 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Jun 28, $GeneDx Holdings(WGS.US)$、$GENEDX HOLDINGS CORP C/WTS 22/07/2026 (TO PUR COM)(WGSWW.US)$ 10% Stockholder OPKO HEALTH, INC. intends to sell 261.42K shares of its common

Moomoo NewsJun 28 09:22 ET

GeneDx Holdings Is Maintained at Buy by BTIG

GeneDx Holdings Is Maintained at Buy by BTIG

Dow JonesJun 26 08:45 ET

BTIG Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $35

BTIG analyst Mark Massaro maintains $GeneDx Holdings(WGS.US)$ with a buy rating, and adjusts the target price from $19 to $35.According to TipRanks data, the analyst has a success rate of 29.1% and a

Moomoo NewsJun 26 08:31 ET · Ratings

GeneDx Hldgs Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/26/2024 28.44% BTIG $19 → $35 Maintains Buy 04/30/2024 -11.93% TD Cowen $14 → $24 Maintains Buy 04/30/2

BenzingaJun 26 08:23 ET

Express News | GeneDx Holdings Corp : Btig Raises Target Price to $35 From $19

ReutersJun 26 07:35 ET